RTW Biotech Opportunities Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 4.17 million compared to USD 2.17 million a year ago. Net income was USD 83.19 million compared to net loss of USD 39.44 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.375 USD | -0.33% | +1.88% | -1.93% |
02:51pm | RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round | MT |
05/04 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
1st Jan change | Capi. | |
---|---|---|
-1.93% | 531M | |
+5.72% | 12.91B | |
+10.99% | 9.59B | |
+0.90% | 5.64B | |
+5.13% | 5.38B | |
+6.18% | 5.21B | |
+20.29% | 4.69B | |
+19.31% | 4.53B | |
+2.49% | 4.07B | |
+7.23% | 3.87B |
- Stock Market
- Equities
- RTWG Stock
- News RTW Biotech Opportunities Ltd
- RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023